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Summary
 
The function of natural killer T (NKT) cells in the immune system has yet to be determined.
There is some evidence that their defect is associated with autoimmunity, but it is still unclear
how they play a role in regulating the pathogenesis of T cell–mediated autoimmune diseases. It
was originally proposed that NKT cells could control autoimmunity by shifting the cytokine
profile of autoimmune T cells toward a protective T helper 2 cell (Th2) type. However, it is
now clear that the major function of NKT cells in the immune system is not related to their
interleukin (IL)-4 secretion. In fact, NKT cells mainly secrete interferon (IFN)-
 
g
 
 and, activated
in the presence of IL-12, acquire a strong inflammatory phenotype and cytotoxic function.
In this study, we have focused our attention on peripheral, IFN-
 
g
 
–secreting NKT cells of non-
obese diabetic (NOD) mice and their ability to immunomodulate the pathogenesis of insulin-
dependent diabetes mellitus (IDDM). We found that in NOD mice, the lack of immunoregu-
 
latory function of NKT cells in vivo
 
 
 
correlated with a dramatic defect in proliferation and
differentiation toward an IFN-
 
g
 
–secreting phenotype upon T cell receptor engagement and
IL-12 stimulation. Peripheral NKT cells may have a critical role balancing inflammatory im-
mune responses and avoiding autoimmunity, such that the functional defect we found in the
NOD mice may ultimately result in autoimmunity through inadequate counterregulation of
the immune response.
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A
 
lthough the role of natural killer T (NKT) cells in the
immune system is not yet fully understood (1, 2), it is
now clear that their dysfunction correlates with the patho-
genesis of T cell–mediated autoimmune diseases. 
 
lpr/lpr
 
 mice
carry a mutation in the Fas gene that is responsible for the
development of a spontaneous autoimmune syndrome re-
sembling human systemic lupus erythematosus. In these
mice, NKT cells disappear from the periphery by the time
the autoimmune disease develops. Moreover, the treatment
of 
 
lpr/lpr
 
 mice with anti-V
 
a
 
14 antibody, which selectively
depletes NKT cells, results in early onset and exacerbation
of autoimmune phenomena (3). NKT cell dysfunction also
correlates with the pathogenesis of experimental allergic
encephalomyelitis (EAE),
 
1
 
 a murine model of T cell–medi-
ated autoimmune disease of the central nervous system. The
high susceptibility of SJL/J mice to EAE is associated with a
striking functional defect of NKT cells (4). Furthermore, the
depletion of NK cells in mice not prone to autoimmune dis-
eases, such as C57BL/6, renders them extremely susceptible to
the induction of severe EAE (5). Nonobese diabetic (NOD)
mice, a strain that develops spontaneous autoimmune diabe-
tes (insulin-dependent diabetes mellitus [IDDM]), have fewer
NKT cells compared with immunologically normal mice.
The quantitative defect is associated with a reduced secre-
tion of cytokines (6). NKT cell dysfunction and IDDM were
unequivocally linked when the injection of thymic NKT
cells from nonautoimmune (NOD 
 
3 
 
BALB/c)F
 
1
 
 mice into
young NOD recipients completely protected the latter from
the onset of IDDM (7, 8). But, whether the increase in
NKT cell number or the restoration of NKT cell function
caused the protection was not determined. In fact, V
 
a
 
14
TCR transgenic NOD mice carrying a large number of
peripheral NKT cells were only partially protected
against IDDM (9), suggesting that the functional, rather
than quantitative, defect of NKT cells correlates with the
pathogenesis of IDDM.
 
1
 
Abbreviations used in this paper:
 
 EAE, experimental autoimmune encepha-
lomyelitis; IDDM, insulin-dependent diabetes mellitus; NOD, nonobese
diabetic. 
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Defect of IFN-
 
g
 
–secreting NKT Cells in T Cell-mediated Autoimmunity
 
Although it is clear that NKT cell dysfunction is related
to the onset of autoimmune diseases, so far there is little
understanding of the mechanisms underlying NKT cell–
mediated protection against autoimmunity. NKT cells can
directly downmodulate T cells in antitumor immunity (10,
11), graft-versus-host disease (12, 13), and rejection of allo-
genic bone marrow stem cells (14). In some cases, the sup-
pression seemed to be mediated by secretion of downmod-
ulatory cytokines such as TGF-
 
b
 
 (10). For this reason, it was
originally proposed that NKT cells could modulate T cell–
mediated autoimmunity by secreting downmodulatory cyto-
kines (8, 9). In fact, NKT cells transferred from thymi of
nonautoimmune mice to NOD donors seemed to mediate
protection through IL-4 and IL-10 secretion. However, it
is still unclear if the cytokine pattern and functional features
of thymic NKT cells are comparable to those of NKT cells
in the periphery. Originally, because NKT cells are the only
T cell subset able to secrete IL-4 primarily upon
 
 
 
in vivo anti-
CD3 stimulation, they have been suggested as the primary
source of this cytokine and, therefore, required for the
generation of Th2-type immune responses (15–17). Yet,
since Th2 immune responses can be generated in 
 
b
 
2-micro-
globulin– or CD1-deficient mice that completely lack
NKT cells (18–20), a fundamental role for this cell subset
in driving Th2 responses can be excluded (21). In fact,
upon TCR-induced stimulation, NKT cells secrete much
more IFN-
 
g
 
 than IL-4, suggesting that their function in
the periphery may be related to their IFN-
 
g
 
–secreting phe-
notype and cytotoxic properties rather than to IL-4 secre-
tion (22–24). In the presence of IL-12, these cells acquire a
strongly biased IFN-
 
g
 
–secreting phenotype completely lack-
ing IL-4 secretion (25, 26). Moreover, activated NKT cells,
which already share several phenotypic markers with NK
cells, can express NK1 and acquire strong, MHC-unrestricted
cytotoxicity against various tumoral NK targets (27–30),
particularly in the presence of IL-12 (31–34). Finally, NKT
cell receptor (V
 
a
 
14-J
 
a
 
281 invariant chain paired with
V
 
b
 
8.2, V
 
b
 
7, or V
 
b
 
2 chains) recognizes glycolipid antigens
presented by CD1, a nonclassical MHC class I–like mole-
cule highly conserved through mammalian evolution (35–37).
All together, these lines of evidence suggest that peripheral
NKT cells, carrying a strong inflammatory phenotype and
cytotoxic properties, could be part of innate immunity and
critical for early clearance of pathogens (38). It is now to be
determined how the defect of peripheral, IFN-
 
g
 
–secreting
NKT cells relates to T cell–mediated autoimmunity.
To correlate the defect of peripheral NKT cells with the
pathogenesis of IDDM, we purified NKT cells from spleens
of NOD mice and analyzed their proliferation and IFN-
 
g
 
secretion in vitro. Our results revealed a generalized dys-
function in NKT cells from NOD mice which encom-
passes their lack of TCR-mediated activation and differen-
tiation toward an IFN-
 
g
 
–secreting phenotype in response
to IL-12 stimulation. In addition, we adoptively transferred
peripheral NKT cells purified from adult NOD mice to
3-wk-old recipients to normalize their otherwise depleted
NKT cell number. The transfer of NKT cells with a defec-
tive IFN-
 
g
 
–secreting phenotype from NOD donors did
not protect from IDDM, suggesting that the functional de-
fect of NOD NKT cells renders them unable to prevent
autoimmunity.
 
Materials and Methods
 
Mice.
 
C57BL/6, NOD/shi, and NOD/Scid mice were bred
and maintained under specific pathogen-free housing conditions at
the Scripps Institute Rodent Colony. Female 3-wk-old NOD
mice were used as recipients in transfer experiments, and 8–10-wk-
old female mice were used as donors and for in vitro experiments.
 
Antibodies.
 
Anti-CD3 mAb (clone 2C11, hamster Ig) for in vivo
treatment was purified from tissue culture supernatants on a protein
G column. Purified anti–TCR-
 
b
 
 (clone H57-597),
 
 
 
PE-conjugated
hamster anti–mouse CD3, FITC-conjugated rat anti–mouse
CD122 (IL-2 receptor 
 
b
 
 chain), and biotinylated rat anti–mouse
Ly49A and streptavidin-cychrome to detect biotinylated anti-
bodies were purchased from PharMingen. For ELISA assay, primary
mAbs anti–IL-4 (clone 11B11) and anti–IFN-
 
g
 
 (clone R46A.2)
and secondary biotinylated anti–IFN-
 
g
 
 (clone XMG1.2) were
purified from ascites, and secondary biotinylated anti–IL-4 (clone
BDV6-24G2) was purchased from PharMingen.
 
Anti-CD3 In Vivo Treatment.
 
To evaluate NKT cell homeo-
stasis in vivo, a group of NOD and C57BL/6 mice were injected
intravenously with purified anti-CD3
 
e
 
 mAb (0.2 
 
m
 
g/mouse) in
200 
 
m
 
l of PBS. The mice were killed after 20 h, and their livers
were collected for cell purification.
 
Cell Preparation.
 
Single cell suspension was prepared from
liver, thymus, and spleen by passing them through nylon mesh.
Splenocytes were treated with hypotonic solution to remove red
blood cells. Total liver cells were resuspended in 40% Percoll
solution (Sigma Chemical Co.) and underlaid with 80% isotonic
Percoll solution. Mononuclear cells were then isolated at the
40/80% interface after centrifugation at 2,000 rpm for 20 min.
 
Flow Cytometric Analysis and Cell Sorting.
 
Single cell suspen-
sions were washed twice with PBS containing 20 mM Hepes
solution to stabilize the pH at 7.3, incubated with PE–anti-CD3,
FITC–anti-CD122, and biotinylated anti-Ly49A primary anti-
bodies at 4
 
8
 
C for 30 min, and after two washes, with the second-
ary reagent, streptavidin-cychrome, at 4
 
8
 
C for 20 min. The cells
were washed again twice and then analyzed on a FACScan™ using
the
 
 
 
CELLQuest™ program. Triple-positive
 
 
 
(CD3
 
1
 
,
 
 
 
Ly49A
 
1
 
, and
CD122
 
1
 
) T cells were sorted using a FACStar
 
PLUS™
 
 (Becton
Dickinson).
 
 
 
Simultaneously,
 
 
 
CD3
 
1
 
, Ly49A
 
2
 
, and CD122
 
2
 
 
 
T cells
were sorted. The sorted T cell populations were 99%
 
 
 
pure and
were used directly for cell culture or adoptive transfer
 
 
 
experiments.
 
Adoptive Transfer Experiments.
 
3 
 
3 
 
10
 
5
 
 NKT cells purified by
FACS
 
®
 
 sorting from total splenocytes of 8–10-wk-old NOD
mice were injected in each 3-wk-old NOD recipient mouse. A
control group was injected with the same number of CD3
 
1
 
NK
 
2
 
T cells. A different group of mice received NKT cells that were
stimulated in vitro in the presence of IL-7 (10
 
3
 
 U/ml) for 3 d
after the sorting. In different experiments, total splenocytes were
completely deleted from NKT cells by FACS
 
®
 
 sorting and then
injected in NOD/Scid mice either with or without 6 
 
3 
 
10
 
5
 
 puri-
fied NKT cells. Blood glucose levels were measured weekly using
Glucofilm blood glucose strips (Miles Diagnostics Division, Inc.).
Mice were considered diabetic after two consecutive measure-
ments of blood glucose level 
 
$
 
250 mg/dl.
 
T Cell Culture and Cytokine Secretion In Vitro.
 
NKT cells freshly
sorted from total thymocyte or splenocyte populations were stim-
ulated in vitro with plate-bound anti–TCR-
 
b
 
 and grown in com-
plete RPMI 1640 medium (GIBCO BRL) supplemented with 
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10% FBS, 50 
 
m
 
M 2-ME, 2 mM 
 
l
 
-glutamine, 100 U/ml penicillin,
200 
 
m
 
g/ml streptomycin, 1 mM sodium pyruvate, and 100 
 
m
 
M
nonessential amino acids. The cells were cultured at a density of 5 
 
3
 
10
 
4
 
 cells/ml in the presence of IL-2 (10 U/ml) alone, or with IL-7
(10
 
3 
 
U/ml) or IL-12 (10ng/ml). IL-2 was added to the cultures ev-
ery 3–4 d, and every week they were restimulated with plate-bound
anti–TCR-
 
b
 
. 48 h after each restimulation, 100 
 
m
 
l of supernatants
was collected from NKT cell cultures for cytokine measurement.
The number of NKT cells/well was the same for NOD and
C57BL/6 samples. We did not observe differences in NKT cell via-
bility between the two groups after cytokine stimulation.
 
NKT Cell Proliferation Assay.
 
96-well plates were coated with
anti–TCR-
 
b
 
 mAb at 10 
 
m
 
g/ml for 2 h at 37
 
8
 
C and washed three
times with cold PBS. Freshly sorted NKT cells were added to the
wells at 10
 
4 
 
cells/well in 200 
 
m
 
l of complete RPMI in duplicates
in the presence of IL-2 alone or with IL-7 or IL-12. After a 2-d
incubation at 37
 
8
 
C, 5% CO
 
2
 
, cells were pulsed with 1 
 
m
 
Ci of
[
 
3
 
H]thymidine for 16 h, and radioactive thymidine incorporation
was measured by a scintillation 
 
b
 
-counter (Wallac).
 
Cytokine Determination by ELISA Assay.
 
Supernatants of anti–
TCR-
 
b
 
 stimulated NKT cell cultures were analyzed for the pres-
ence of IL-4 or IFN-
 
g
 
 using an ELISA assay. In brief, ELISA
96-well plates (Nunc) were coated with primary mAb anti–IL-4
at 4 
 
m
 
g/ml or anti–IFN-
 
g
 
 at 2 
 
m
 
g/ml diluted in PBS overnight at
4
 
8
 
C. After washes with PBS containing 0.05% Tween and incu-
bation with blocking solution (PBS/Tween containing 1% BSA
and 10% FBS), the supernatant samples were added to the wells at
serial fivefold dilutions and incubated overnight at 4
 
8
 
C. Recom-
binant murine IFN-
 
g
 
 and IL-4 (PharMingen) were used as stan-
dards.
 
 
 
Biotinylated secondary antibody anti–IFN-
 
g
 
 or anti–IL-4
at 1 
 
m
 
g/ml and streptavidin-peroxidase plus H
 
2
 
O
 
2
 
–based devel-
oping system were used to detect the amount of cytokines. The
concentrations of IFN-
 
g
 
 and IL-4 were interpolated using the
Softmax program against the linear range on the standard curves
(40–2,500 pg/ml).
 
Statistical Analysis.
 
Differences in proliferation assay, cytokine
secretion, and diabetes incidence were analyzed using the Student’s
 
t
 
 test.
 
Results
 
NKT Cells of NOD Mice Have a Defect in TCR-mediated
Activation.
 
It has been reported that primary cytokine se-
cretion upon anti-CD3 stimulation of thymic NKT cells is
defective in NOD mice, but it is still unclear where the
functional defect of peripheral NKT cells lies. We analyzed
the ability of NKT cells from spleens of NOD mice to re-
spond to anti-TCR–mediated activation. NKT cells were
isolated by three-color staining with antibodies against
markers of T cells (anti-CD3–PE) and NK cells (anti-
Ly49A–cychrome and anti–IL-2 receptor 
 
b
 
 chain–FITC)
followed by FACS
 
®
 
 sorting of triple-positive lymphocytes.
Freshly sorted NKT cells of NOD mice were activated in
vitro with plate-bound anti–TCR-
 
b
 
 antibody. NKT cells
from C57BL/6 mice were used as controls. Several cyto-
kines known to act as growth factors for NKT cells were
then added to the NKT cell cultures to determine their ef-
fect on the anti-TCR–mediated proliferation. As Fig. 1 A
illustrates, the proliferative response of NKT cells from
NOD mice either without cytokines or in the presence of
IL-2 was significantly reduced compared with the same T
cell population of C57BL/6 mice (
 
P
 
 , 0.05). Next, IL-7
was also added because it has been shown to induce in vitro
maturation and growth of thymic NKT cells from NOD
mice (39). However, in our experiment IL-7 did not mod-
ify the defect in TCR-mediated stimulation in peripheral
NKT cells of NOD mice. This defect became even more
Figure 1. The proliferative response to
TCR plus IL-12–mediated stimulation is af-
fected in peripheral NKT cells of NOD
mice. (A) The NKT cells were stained with
the cocktail of three antibodies against
markers of T cells (anti-CD3–PE) and NK
cells (anti-Ly49A–cychrome and anti–IL-2
receptor b chain–FITC) and purified by
FACS® sorting. Freshly sorted NKT cells
from splenocytes of NOD and C57BL/6
mice were in vitro stimulated in TCR-
b–bound 96-well plates. IL-2 alone or with
IL-7 or IL-12 was added to the cultures to
measure their effect on TCR-mediated
stimulation of NKT cells. The degree of
proliferation was measured by [3H]thymi-
dine incorporation and expressed as cpm 6
SD. NKT cells of NOD (hatched bars) mice
showed a reduced proliferation with or
without the addition of cytokines to the cul-
tures compared with the same T cell popula-
tion isolated from spleens of age-matched
C57BL/6 mice (black bars). The impaired proliferation was even more striking in the NOD NKT cell cultures stimulated with IL-12. Data are from one
representative experiment out of three and represent the geometric mean of duplicate determinations. (B) NKT cells sorted from NOD or C57BL/6 sple-
nocytes were cultured in anti–TCR-b bound 24-wells plate in the presence of IL-12. The number of peripheral NKT cells found in spleens of NOD
mice was lower than that of C57BL/6 mice (black bars). The NKT cell number difference became more evident after TCR plus IL-12–mediated stimu-
lation. While NKT cells of C57BL/6 expanded significantly after 4 d of culture (50% increase), NKT cells of NOD mice did not amplify in culture
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dramatic in the presence of IL-12, a critical cytokine for
NKT cell activation and differentiation toward the IFN-g–
secreting phenotype. As expected, IL-12 added to like cul-
tures from C57BL/6 mice enhanced TCR-mediated pro-
liferation of NKT cells. Strikingly, IL-12 had no effect on
NKT cells of NOD mice. In addition, we found that the
expansion of the NKT cell population in response to anti-
TCR plus IL-12 stimulation was also effected in NOD
mice. In fact, after 3 d of culture in the presence of IL-12,
anti-TCR–stimulated NKT cells of C57BL/6 mice showed
a numerical increase of 50%. In contrast, there was no increase
and even a slight decrease (5%) in the number of NKT cells
from NOD mice, most likely related to cell death (Fig. 1 B).
IL-12–induced Differentiation toward an IFN-g–secreting
Phenotype Is Defective in Peripheral NKT Cells of NOD Mice.
It has been proposed that NKT cells may regulate auto-
immunity by secreting cytokines such as IL-4 and IL-10 that
are downmodulatory for the Th1 cytokine pathway. In ad-
dition, it has been reported that patients affected by IDDM
have a defect selectively on IL-4 secretion by NKT cells
(40), although it recently emerged that the functional de-
fect of NKT cells of IDDM patients does not involve only
IL-4 secretion (Wilson, B., personal communication). More-
over, it is now clear that the function of peripheral NKT
cells is related to their IFN-g–secreting phenotype and in-
flammatory features (22–24, 27–30). Therefore, we investi-
gated the ability of NKT cells from NOD mice to differ-
entiate toward an IL-4– or IFN-g–secreting phenotype to
determine if they carry a defect in differentiation toward a
specific cytokine pathway.
To establish cytokine phenotype, NKT cells isolated
from the thymi and spleens of NOD and C57BL/6 mice
were examined by IL-4 and IFN-g ELISA assays on super-
natants of anti-TCR–stimulated NKT cells. We found that
normal NKT cells from thymocytes of C57BL/6 mice had
a predominant IL-4–secreting phenotype in accordance with
the observation that NKT cells from the thymi of normal
(BALB/c 3 NOD)F1 mice protected NOD mice through
secretion of IL-4 (8). NKT cells isolated from thymi of
NOD mice not only secreted lower amounts of both cy-
tokines but, in particular, were unable to secrete IL-4. This
defect can be related to the lack of maturation of NOD
NKT cells in the thymus. Several studies have now shown
that NKT cells, once they reach secondary lymphoid tissue,
acquire a strong IFN-g–secreting phenotype. In fact, when
we measured cytokine secretion of NKT cells isolated from
spleens of C57BL/6, we observed a complete shift toward
an IFN-g–secreting phenotype (Fig. 2, and Table I). Strik-
ingly, peripheral NKT cells from spleens of NOD mice
showed no increase in cytokine secretion and did not dif-
ferentiate toward the IFN-g cytokine phenotype as did
normal C57BL/6 NKT cells.
Since IL-12 is considered a critical cytokine in matura-
tion and differentiation of NKT cells (25, 26, 31–34), we
investigated the ability of IL-12 to drive peripheral NKT
cells from NOD mice toward a strong IFN-g–secreting
phenotype. NKT cells purified from spleens of NOD and
C57BL/6 mice were activated in vitro by anti-TCR stim-
ulation in the presence of IL-7 or IL-12. Secretion of IL-4
and IFN-g was then measured both during primary stimu-
lation and after continuous stimulation in the presence of cy-
tokines. As expected, peripheral NKT cells from C57BL/6
mice secreted higher amounts of IFN-g than IL-4. In ad-
dition, IL-12 abolished IL-4 secretion while dramatically
increasing IFN-g secretion in the NKT cell cultures (Fig.
Table I. Cytokine-secreting Phenotype of NKT Cells
Thymus Spleen
C57BL/6 mice IL-4 . IFN-g IFN-g .. IL-4
NOD mice IFN-g . IL-4 IFN-g 5 IL-4
Figure 2. NKT cells of NOD mice failed
to differentiate toward an IFN-g–secreting
phenotype in the periphery. The cytokine
profile of NKT cells in the thymi and spleens
of normal C57BL/6 and NOD mice was
evaluated by IFN-g and IL-4 ELISA assays.
Freshly sorted NKT cells were briefly stimu-
lated in vitro by plate-bound anti-TCR an-
tibody, and supernatants were analyzed for
IFN-g (black bars) and IL-4 secretion
(hatched bars). Normal NKT cells of
C57BL/6 mice in the thymus secrete a larger
amount of IL-4 than IFN-g. Once in the
periphery, their cytokine phenotype
changed, and they differentiated toward a
strongly biased IFN-g–secreting phenotype
with almost undetectable IL-4 secretion. Pe-
ripheral NKT cells of NOD mice fail to ac-
quire the IFN-g-secreting phenotype and
they do not increase their IFN-g secretion;
however, at the same time, they retain the
ability to secrete IL-4.967 Falcone et al.
3 A). On the other hand, in the NOD mice the secretion
of IFN-g in response to IL-12 stimulation was significantly
lower (P , 0.05; Fig. 3 B). The lack of differentiation
toward an IFN-g phenotype was even more striking in
NOD NKT cell cultures repetitively stimulated in the
presence of IL-12 (Fig. 3 B).
Lack of Rapid Turnover of NKT Cells in the NOD Mice.
It has been shown recently that IL-12– or anti-CD3–medi-
ated activation in vivo induces pronounced cell death in
peripheral NKT cells in ,24 h, after which their number is
rapidly restored by regeneration from bone marrow stem
cells (41). This uniquely rapid turnover seems necessary to
prevent NKT cells from interfering with acquired immune
responses. In other words, activated NKT cells with a bi-
ased IFN-g–secreting phenotype must be rapidly removed
once they clear pathogens, so as to halt inflammatory im-
mune responses that are no longer required. To evaluate
homeostasis of peripheral NKT cells in NOD mice, we an-
alyzed the degree of CD31 cell depletion in the liver, where
z50% of the T cells are NKT cells. NOD and C57BL/6
mice were injected with anti-CD3 antibody, and the total
number of CD31 lymphocytes in the liver was measured
by FACS® analysis. Fig. 4 shows that CD31 lymphocytes
of C57BL/6 mice decrease by 50% at 20 h after anti-CD3
antibody injection. This CD31 cell depletion could reflect
the death of NKT cells, since previous studies have shown
that other T cell populations in the liver are not affected by
anti-CD3 administration. We confirmed that the depleted
Figure 3. IL-12 did not induce IFN-g secretion
in NKT cells of NOD mice. We analyzed the abil-
ity of IL-12 to induce IFN-g secretion in peripheral
NKT cells of NOD mice. NKT cells from total
splenocytes of C57BL/6 and NOD mice were iso-
lated by FACS® sorting and cultured with repeated
anti-TCR stimulations in the presence of IL-2 with
IL-7 (black bars) or IL-12 (hatched bars). The su-
pernatants of the NKT cell cultures were collected
48 h after each restimulation and analyzed by IFN-g
and IL-4 ELISA assays. (A) Already at the first stim-
ulation, NKT cells of C57BL/6 mice secreted IFN-g
in larger amounts than IL-4, particularly when IL-12
was added to the cultures. Noticeably, IL-12 was
able to inhibit IL-4 secretion by NKT cells. NKT
cells of NOD mice responded less intensively to
IL-12 and secreted lower amounts of IFN-g. (B)
The defect of IL-12–induced IFN-g secretion in
NKT cells of NOD mice became more evident af-
ter continuous in vitro stimulations. At the third re-
stimulation, while NKT cells from normal mice
secreted z500 ng of IFN-g per milliliter of super-
natant, the same cells from NOD mice did not in-
crease their IFN-g secretion at all. These data are
from one representative experiment out of three.
Figure 4. Lack of rapid turnover in pe-
ripheral NKT cells of NOD mice. The ho-
meostasis of peripheral NKT cells was evalu-
ated by measuring CD31 lymphocytes in the
liver of C57BL/6 and age-matched NOD
mice injected intravenously with anti-CD3
mAb. Control mice were injected with PBS.
After 20 h, the lymphocyte population of the
liver was isolated and analyzed by FACS®
sorting. In C57BL/6 mice, anti-CD3 treat-
ment reduced the CD31 cells in the liver
z50% (from 62.3 to 31.7% lymphocytes), a
reduction that can be integrally related to
NKT cell depletion. On the contrary, the
same T cell population in the liver of NOD
mice showed only a slight decrease (from
52.6 to 48%). The data are from one repre-
sentative experiment out of two.968 Defect of IFN-g–secreting NKT Cells in T Cell-mediated Autoimmunity
CD31 T cell population in C57BL/6 mice carried markers
of NKT cells such as NK1.1 (data not shown). Strikingly,
in NOD mice the same CD31 population was not at all
affected by anti-CD3 stimulation. Our results suggest that
peripheral NKT cells of NOD mice, once activated in vivo,
did not undergo a rapid deletion, a phenomenon that can
be ascribed to their defective TCR-mediated activation.
Peripheral NKT Cells Isolated from NOD Mice Do Not
Mediate Protection against IDDM. Because NOD mice have
fewer circulating NKT cells than nonautoimmune strains
of mice, we questioned whether this quantitative defect is
the only defining factor, or whether the functional defect
we found in peripheral NKT cells of NOD mice could be
crucial for the pathogenesis of IDDM. First, we transferred
3 3 105 purified NKT cells from adult NOD mice to
markedly enlarge the NKT cell subset in young syngeneic
recipients. NKT cells from splenocytes of 8–10-wk-old
donors were stained with markers of T cells (anti-CD3)
and NK cells (anti-Ly49A and anti–IL-2 receptor b chain).
The triple-positive cells were isolated by FACS® sorting
and injected into 3-wk-old NOD mice. A control group
received only phosphate buffer solution. The NOD trans-
fer recipients, despite carrying an NKT cell repertoire dou-
ble that of untreated NOD mice, were only partially pro-
tected against IDDM (Fig. 5). However, the difference in
diabetes incidence between the two groups of mice was
not statistically significant (P . 0.05) at any point in the
age-related curve.
Normal NKT cells in the periphery predominantly carry
an IFN-g–secreting phenotype, so the lack of protection
from IDDM by a large number of peripheral NKT cells
could be integrally ascribed to their functional defect in
IFN-g secretion. To further support this hypothesis, we
isolated NKT cells from the spleens of NOD donors and
stimulated them in vitro with IL-7, after which they were
transferred into 3-wk-old recipients. This cytokine has
been reported to be capable of stimulating IL-4 secretion
by NOD NKT cells (39). In fact, after 3 d in vitro stimula-
tion with IL-7, NKT cells of NOD mice showed a normal
IL-4 secretion but were weak in IFN-g secretion (as shown
in Fig. 3, A and B). Although their IL-4 secretion was am-
plified, IL-7–stimulated NKT cells were still unable to pro-
tect against IDDM (Fig. 5). Furthermore, the group of mice
that received IL-7–stimulated NKT cells did not show the
slight decrease in IDDM incidence that we found in NOD
mice treated with freshly sorted, IFN-g–secreting NKT
cells. This demonstrates that the administration of Th2-dif-
ferentiated NKT cells does not counterregulate, but rather
worsens, IDDM pathogenesis. We found that the dramatic
defect in proliferation and IFN-g secretion in response to
IL-12 rendered us unable us to induce NOD NKT cells to-
ward the Th1 cytokine–secreting phenotype.
We also tested the ability of NOD NKT cells to immu-
noregulate the effector phase of IDDM and downmodulate
diabetogenic T cells. For that purpose, 107 total splenocytes
were isolated from prediabetic NOD mice (14-wk-old),
depleted of NKT cells by FACS® sorting, and injected in
NOD/Scid recipients. Another group of NOD/Scid mice
received the same number of NKT-depleted splenocytes
plus 6 3 105 purified NKT cells. The onset and incidence
Figure 5. Peripheral NKT cells of NOD
mice can only mediate incomplete protec-
tion against IDDM. The NKT cell reper-
toire of 3-wk-old NOD mice was signifi-
cantly enlarged by intravenous injection of
3 3 105 NKT cells (CD31, CD1221, and
Ly49A1 cells) purified by FACS® sorting
from spleens of 8–10-wk-old NOD donors.
Some of the freshly isolated NKT cells were
cultured for 3 d in the presence of IL-7 to
restore a normal IL-4 secretion. A control
group received phosphate buffer solution.
Blood glucose levels were measured weekly
starting at 10 wk of age. Mice with blood
glucose values $250 mg/dl were consid-
ered diabetic. Starting at 16 wk of age, the
PBS-injected controls (u; n 5 11) as well as
the mice that received IL-7–stimulated
NKT cells (s; n 5 6) developed diabetes
with a similar time course. Mice that re-
ceived a large number of peripheral NKT
cells started developing diabetes later and
with a lower incidence (n; n 5 7). How-
ever, at 22 wk of age, 42% of the NKT-
injected mice had developed diabetes, and
the difference in diabetes incidence com-
pared with the control group was not statisti-
cally significant (P . 0.05) at any time point
on the age-related curve. The data are cu-
mulative from three different experiments.969 Falcone et al.
of IDDM in the two groups of mice were identical (Fig. 6),
indicating that a functional rather than numerical defect in
peripheral NKT cells renders them unable to mediate im-
munoprotection against IDDM.
Discussion
The function of NKT cells in the immune system appears
strongly related to their IFN-g secretion and cytotoxic prop-
erties (22–24, 27–30). Our results clearly showed that pe-
ripheral NKT cells of NOD mice carry a pronounced defect
in their TCR-mediated– and IL-12–induced activation and
IFN-g secretion. The lack of these inflammatory features
associated with the inability to offset IDDM, which we
found in NKT cells of NOD mice, suggests that the defect
of their IFN-g–secreting phenotype may be involved in T
cell–mediated autoimmunity.
The involvement of the NKT cells in modulation of
autoimmunity is, in fact, proved by the observation that a
defect of the NKT cell population is invariably associated
with T cell–mediated autoimmune diseases. NOD mice
which develop spontaneous IDDM, as well as other auto-
immune-prone strains of mice, have a paucity of NKT cells
(4, 6). In young NOD mice, the restoration of a normal
NKT cell repertoire by transfer of NKT cells from non–auto-
immune-prone mice conferred protection from IDDM (7,
8). However, we showed here that the restoration of a
functional NKT cell population rather than simply an in-
crease in cell number may be critical to offset IDDM. In
fact, the transfer of NKT cells from adult, prediabetic NOD
mice to young NOD recipients did not significantly affect
the disease. Yet, transfer of diabetogenic T cells into NOD/
Scid mice induced IDDM whether NKT cells were absent
or coinjected in large numbers. These findings agree with a
recent report showing that Va14 TCR transgenic mice,
despite an extremely large NKT cell population, developed
IDDM, albeit at a reduced frequency (9). Therefore, it is
now clear that a functional rather than quantitative defect
of NKT cell correlates with the pathogenesis of IDDM.
However, the nature of this defect in NOD mice is still
unclear. Previous studies in NOD mice and individuals af-
fected by IDDM have shown that NKT cells are defective
specifically in IL-4 secretion (6, 40). This finding, together
with the observation that IL-4 is required for (BALB/c 3
NOD)F1 NKT cells to mediate protection against IDDM
(8), had supported the hypothesis that the secretion of IL-4
is associated with NKT cell–mediated regulation of au-
toimmunity. However, this hypothesis is in sharp contrast
to many studies showing that normal NKT cells in the pe-
riphery have a strong IFN-g–secreting phenotype and do
not secrete large amounts of IL-4. Therefore, we analyzed
peripheral, IFN-g–secreting NKT cells in NOD mice and
found that their defect was more generalized, involved
their IFN-g secretion, and could relate to the pathogenesis
of IDDM in distinct ways.
The marked lack of proliferation and expansion of NKT
cells in response to TCR-mediated activation that we re-
ported could account for the typically limited number of
these cells in NOD mice (6). Moreover, the defect in TCR-
mediated activation might dramatically compromise the
ability of NKT cells to respond to their specific ligand, the
CD1 molecule (42). CD1 recognition in the thymus, and
probably also in the periphery, is a critical signal for matu-
ration of NKT cells (43–46). In fact, CD1 knockout mice
carry an NKT cell repertoire that is defective in cytokine
secretion (19), a defect similar to that which we found in
NOD mice.
The defect in NKT cell activation and response to IL-12
may also affect their homeostasis, i.e., turnover rate, in
NOD mice. Like many cells belonging to the innate im-
mune system, activated NKT cells, differentiated toward a
strong IFN-g–secreting phenotype, are required in the
early stages of an immune response against pathogens, and
then they need to be rapidly removed from the site of in-
flammation so as not to interfere with the secondary T cell
responses. Both IL-12 and anti-CD3 activation induce a
dramatic cell death among the NKT cell subset (40). NKT
cells may be refractory to activation through the IL-12 re-
ceptor or TCR–CD3 complex. The lack of rapid homeo-
stasis of peripheral, IFN-g–secreting NKT cells that we
found in NOD mice could be the result of this defect,
which predisposes them to sustain unnecessary Th1 inflam-
matory responses, including autoreactive responses, and ul-
timately poses the risk of T cell–mediated autoimmunity.
An alternative hypothesis holds that peripheral NKT
cells with a strong IFN-g–secreting phenotype could be
Figure 6. NKT cells of NOD mice had no immunomodulatory effect
on the effector phase of IDDM. To test if NKT cells from NOD mice
could have any immunoregulatory role on diabetogenic effector T cells,
we transferred diabetogenic splenocytes from NOD mice (14-wk-old) to
NOD/Scid recipients with or without NKT cells. In brief, total spleno-
cytes were stained for the three NKT cell markers (CD3, CD122, and
Ly49A) and FACS® sorted. The NKT cell–negative splenocytes were
then injected in NOD/Scid recipients with or without 6 3 105 triple-
positive NKT cells. The NOD/Scid mice that received NKT cells to-
gether with the diabetogenic splenocytes (j; n 5 4) showed the same
clinical course and incidence of diabetes as the mice that were injected
with NKT cell–depleted splenocytes (u; n 5 4). The data are cumulative
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critical to directly dampen the destructive potential of au-
toreactive T cells. Contrary to the belief that NKT cells
could prevent the onset of autoimmune diseases by secret-
ing downmodulatory cytokines such as IL-4, we found that
IL-4 secretion by peripheral NKT cells may be not so criti-
cal to offset IDDM. In fact, the release of IL-4 by periph-
eral NKT cells is minimal compared with IFN-g secretion.
In other words, normal NKT cells in the thymus secreted
large amounts of IL-4 in our experiments, perhaps the
route of IL-4–mediated protection from IDDM that NKT
cells from thymocytes of nonautoimmune mice induced in
NOD mice. However, our results showed that once nor-
mal NKT cells of C57BL/6 mice reach the periphery, they
acquire a strongly biased IFN-g–secreting phenotype. On
the other hand, peripheral NKT cells of NOD mice failed
to respond to activation and underwent IFN-g phenotype
differentiation induced by IL-12, thus suggesting that the
defect in the IFN-g–secreting phenotype of peripheral
NKT cells may correlate with the pathogenesis of IDDM
in the NOD mice. This hypothesis has been further sup-
ported by our finding that restoring a normal IL-4–secret-
ing phenotype in NOD NKT cells before their transfer in
young syngeneic recipients did not enhance their ability to
offset the pathogenesis of IDDM. Several lines of evidence
indicate that cytokines belonging to the Th1 pathway are
ultimately needed to prevent pathogenic autoimmunity.
Interestingly, the expression of IFN-g in the pancreatic is-
lets protects NOD mice from IDDM, and removal of Th1
cytokines such as IFN-g exacerbated T cell–mediated au-
toimmune diseases (47–49). IFN-g has been proposed to
play a direct role in downmodulation of T cell immunity
(50–52). In fact, IFN-g is able to induce cell death on ef-
fector T cells that are activated by TCR cross-linking in
the absence of costimulatory signals, a mechanism that
seems critical for maintaining immune tolerance to self-
antigens (53). It has been previously shown that regulatory
T cells such as TCR-specific CD41 T cells protect from T
cell–mediated autoimmunity through secretion of IFN-g
(54). We believe that peripheral NKT cells with a strong
IFN-g–secreting phenotype could directly downmodulate
Th1-type autoimmunity by releasing large amounts of
IFN-g in the microenvironment. Alternatively, they could
directly eliminate Th1-autoreactive cells by Fas-mediated
cytotoxicity (28, 30). NKT cells with a strongly biased
IFN-g–secreting phenotype and cytotoxic properties could
participate in T cell–mediated immunity. At the same time,
the burst of IFN-g secretion induced by NKT cells in the
microenvironment could be critical to turn off unnecessary
T cell immune responses, including autoreactive responses.
Our viewpoint is paradoxical with the earlier finding that
administration of IL-12 leads to accelerated diabetes in the
NOD mouse (55). Indeed, widespread polarized Th1 re-
sponses are highly diabetogenic; however, the amplification
of such responses may be thwarted by the NKT cell coun-
terregulatory functions described here. We believe that the
secretion of IL-4 by peripheral NKT cells is less critical for
downregulation of T cell–mediated autoimmunity. In fact,
the amount of IL-4 released by NKT cells in the periphery
is minimal compared with the secretion of IFN-g. More-
over, we found that the restoration of normal IL-4 secre-
tion by NOD NKT cells before their transfer in young
syngeneic recipients did not improve, but rather worsened,
their ability to downregulate autoimmunity.
There is now extensive evidence that a defect of the
NKT cell subset is invariantly associated with T cell–medi-
ated autoimmunity in mice as well as in patients affected by
IDDM. We believe that the association between a lack of
IFN-g–secreting phenotype of NKT cells and IDDM in
NOD mice suggests a critical homeostatic role for IFN-g
in regulation of T cell immunity. IFN-g–secreting T cell
subsets such as NKT cells that actively participate in innate
immune responses against pathogens may also be critical for
counterregulation of autoimmunity so that their functional
defect leads, by default, to disease.
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